|
1
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Turner JH and Reh DD: Incidence and
survival in patients with sinonasal cancer: A historical analysis
of population-based data. Head Neck. 34:877–885. 2012. View Article : Google Scholar
|
|
3
|
Brodeur GM: Neuroblastoma: Biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schwab M, Alitalo K, Klempnauer KH, Varmus
HE, Bishop JM, Gilbert F, Brodeur G, Goldstein M and Trent J:
Amplified DNA with limited homology to myc cellular oncogene is
shared by human neuroblastoma cell lines and a neuroblastoma
tumour. Nature. 305:245–248. 1983. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Caron H: Allelic loss of chromosome 1 and
additional chromosome 17 material are both unfavourable prognostic
markers in neuroblastoma. Med Pediatr Oncol. 24:215–221. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Attiyeh EF, London WB, Mosse YP, Wang Q,
Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, et
al: Chromosome 1p and 11q deletions and outcome in neuroblastoma. N
Engl J Med. 353:2243–2253. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Carpenter EL and Mosse YP: Targeting ALK
in neuroblastoma - preclinical and clinical advancements. Nat Rev
Clin Oncol. 9:391–399. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oberthuer A, Hero B, Berthold F, Juraeva
D, Faldum A, Kahlert Y, Asgharzadeh S, Seeger R, Scaruffi P, Tonini
GP, et al: Prognostic impact of gene expression-based
classification for neuroblastoma. J Clin Oncol. 28:3506–3515. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baker DL, Schmidt ML, Cohn SL, Maris JM,
London WB, Buxton A, Stram D, Castleberry RP, Shimada H, Sandler A,
et al: Outcome after reduced chemotherapy for intermediate-risk
neuroblastoma. N Engl J Med. 363:1313–1323. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Younan S, Elhoseiny S, Hammam A, Gawdat R,
El-Wakil M and Fawzy M: Role of neuropilin-1 and its expression in
Egyptian acute myeloid and acute lymphoid leukemia patients. Leuk
Res. 36:169–173. 2012. View Article : Google Scholar
|
|
11
|
Li L, Jiang X, Zhang Q, Dong X, Gao Y, He
Y, Qiao H, Xie F, Xie X and Sun X: Neuropilin-1 is associated with
clinicopathology of gastric cancer and contributes to cell
proliferation and migration as multifunctional co-receptors. J Exp
Clin Cancer Res. 35:162016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Y, Liu P, Jiang Y, Dou X, Yan J, Ma
C, Fan Q, Wang W, Su F, Tang H, et al: High expression of
neuropilin-1 associates with unfavorable clinicopathological
features in hepatocellular carcinoma. Pathol Oncol Res. 22:367–375.
2016. View Article : Google Scholar
|
|
13
|
Zhu H, Cai H, Tang M and Tang J:
Neuropilin-1 is overexpressed in osteosarcoma and contributes to
tumor progression and poor prognosis. Clin Transl Oncol.
16:732–738. 2014. View Article : Google Scholar
|
|
14
|
Ben Q, Zheng J, Fei J, An W, Li P, Li Z
and Yuan Y: High neuropilin 1 expression was associated with
angiogenesis and poor overall survival in resected pancreatic
ductal adenocarcinoma. Pancreas. 43:744–749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi F, Shang L, Yang LY, Jiang YY, Wang
XM, Hao JJ, Zhang Y, Huang DK, Cai Y, Xu X, et al: Neuropilin-1
contributes to esophageal squamous cancer progression via promoting
P65-dependent cell proliferation. Oncogene. 37:935–943. 2018.
View Article : Google Scholar
|
|
16
|
Fuh G, Garcia KC and de Vos AM: The
interaction of neuropilin-1 with vascular endothelial growth factor
and its receptor flt-1. J Biol Chem. 275:26690–26695.
2000.PubMed/NCBI
|
|
17
|
Jubb AM, Strickland LA, Liu SD, Mak J,
Schmidt M and Koeppen H: Neuropilin-1 expression in cancer and
development. J Pathol. 226:50–60. 2012. View Article : Google Scholar
|
|
18
|
Fakhari M, Pullirsch D, Abraham D, Paya K,
Hofbauer R, Holzfeind P, Hofmann M and Aharinejad S: Selective
upregulation of vascular endothelial growth factor receptors
neuropilin-1 and -2 in human neuroblastoma. Cancer. 94:258–263.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prud'homme GJ and Glinka Y: Neuropilins
are multifunctional coreceptors involved in tumor initiation,
growth, metastasis and immunity. Oncotarget. 3:921–939. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ruffini F, D'Atri S and Lacal PM:
Neuropilin-1 expression promotes invasiveness of melanoma cells
through vascular endothelial growth factor receptor-2-dependent and
-independent mechanisms. Int J Oncol. 43:297–306. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Glinka Y, Mohammed N, Subramaniam V, Jothy
S and Prud'homme GJ: Neuropilin-1 is expressed by breast cancer
stem-like cells and is linked to NF-κB activation and tumor sphere
formation. Biochem Biophys Res Commun. 425:775–780. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Glinka Y, Stoilova S, Mohammed N and
Prud'homme GJ: Neuropilin-1 exerts co-receptor function for
TGF-beta-1 on the membrane of cancer cells and enhances responses
to both latent and active TGF-beta. Carcinogenesis. 32:613–621.
2011. View Article : Google Scholar
|
|
23
|
Chen HC and Guan JL: Association of focal
adhesion kinase with its potential substrate phosphatidylinositol
3-kinase. Proc Natl Acad Sci USA. 91:10148–10152. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Westhoff MA, Serrels B, Fincham VJ, Frame
MC and Carragher NO: SRC-mediated phosphorylation of focal adhesion
kinase couples actin and adhesion dynamics to survival signaling.
Mol Cell Biol. 24:8113–8133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fiaschi T, Cozzi G, Raugei G, Formigli L,
Ramponi G and Chiarugi P: Redox regulation of beta-actin during
integrin-mediated cell adhesion. J Biol Chem. 281:22983–22991.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lassing I, Schmitzberger F, Bjornstedt M,
Holmgren A, Nordlund P, Schutt CE and Lindberg U: Molecular and
structural basis for redox regulation of beta-actin. J Mol Biol.
370:331–348. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Neufeld G and Kessler O: The semaphorins:
Versatile regulators of tumour progression and tumour angiogenesis.
Nat Rev Cancer. 8:632–645. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Serini G, Valdembri D, Zanivan S, Morterra
G, Burkhardt C, Caccavari F, Zammataro L, Primo L, Tamagnone L,
Logan M, et al: Class 3 semaphorins control vascular morphogenesis
by inhibiting integrin function. Nature. 424:391–397. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Herman JG and Meadows GG: Increased class
3 semaphorin expression modulates the invasive and adhesive
properties of prostate cancer cells. Int J Oncol. 30:1231–1238.
2007.PubMed/NCBI
|
|
30
|
Pan H, Wanami LS, Dissanayake TR and
Bachelder RE: Autocrine semaphorin3A stimulates alpha2 beta1
integrin expression/function in breast tumor cells. Breast Cancer
Res Treat. 118:197–205. 2009. View Article : Google Scholar
|
|
31
|
Park H, Choi HJ, Kim J, Kim M, Rho SS,
Hwang D, Kim YM and Kwon YG: Homeobox D1 regulates angiogenic
functions of endothelial cells via integrin β1 expression. Biochem
Biophys Res Commun. 408:186–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Keely S, Glover LE, MacManus CF, Campbell
EL, Scully MM, Furuta GT and Colgan SP: Selective induction of
integrin beta1 by hypoxia-inducible factor: Implications for wound
healing. FASEB J. 23:1338–1346. 2009. View Article : Google Scholar :
|
|
33
|
Hamurcu Z, Kahraman N, Ashour A and
Ozpolat B: FOXM1 transcriptionally regulates expression of integrin
β1 in triple-negative breast cancer. Breast Cancer Res Treat.
163:485–493. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kolodkin AL, Levengood DV, Rowe EG, Tai
YT, Giger RJ and Ginty DD: Neuropilin is a semaphorin III receptor.
Cell. 90:753–762. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
He Z and Tessier-Lavigne M: Neuropilin is
a receptor for the axonal chemorepellent Semaphorin III. Cell.
90:739–751. 1997. View Article : Google Scholar : PubMed/NCBI
|
